Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Apr 17, 2018 at 10:40 AM EDT

Why Now Is the Best Time for Bellicum to Raise Cash

Bellicum Pharmaceuticals shares pulled back on Tuesday after the firm announced that it would be conducting a secondary offering to…

Jon C. Ogg | Apr 17, 2018 at 10:25 AM EDT

An Upcoming Drug May Emerge as the Winner in the War on Chronic Severe Gout

Many of the gout treatments on the market have been the same for decades, and many of them can come…

Jon C. Ogg | Apr 17, 2018 at 10:00 AM EDT

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA…

Chris Lange | Apr 17, 2018 at 9:45 AM EDT

Johnson & Johnson Earnings Just Par for the Course

Johnson & Johnson (NYSE: JNJ) reported its first quarter financial results before the markets opened on Tuesday. The company said…

Chris Lange | Apr 17, 2018 at 8:40 AM EDT

Why UnitedHealth Is Boasting Healthy Earnings

UnitedHealth released a better-than-expected quarterly earnings report before the markets opened on Tuesday.

Jon C. Ogg | Apr 17, 2018 at 7:40 AM EDT

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Lung cancer may have just met a new standard of care. On top of that, it would be considered a new…

Chris Lange | Apr 16, 2018 at 11:00 AM EDT

Why NewLink Genetics Shares Hit an All-Time Low

NewLink Genetics shares hit an all-time low in Monday’s session after the company provided an update on its brain tumor…

Chris Lange | Apr 16, 2018 at 9:55 AM EDT

Alkermes Wins Big on FDA Approval

Shares of Alkermes saw a handy gain to start out the week after the FDA made a critical decision about…

Chris Lange | Apr 16, 2018 at 8:40 AM EDT

Why Celldex Therapeutics Is Getting Crushed

Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.

Lee Jackson | Apr 16, 2018 at 8:15 AM EDT

Why 4 Top Biotech Stocks May Be the Next Takeover Targets

These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs…

Chris Lange | Apr 14, 2018 at 8:35 AM EDT

6 Biotech and Medtech Stocks That Saw Massive Moves Last Week

Over the past week, a few biotech companies made absolutely massive runs, while others fell off a cliff. Although health…

Chris Lange | Apr 12, 2018 at 10:55 AM EDT

Bellicum Pharmaceuticals Wins Big With FDA Decision

Bellicum Pharmaceuticals saw its shares rise early on Thursday after the firm announced a critical decision from the FDA.

Chris Lange | Apr 11, 2018 at 1:25 PM EDT

Pfizer’s Kidney Drug Not Up to Par

Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.

Chris Lange | Apr 11, 2018 at 10:35 AM EDT

Are Analogic Shareholders Getting Enough in the Buyout?

Usually, when companies are being acquired they receive a premium on their share price. This does not seem to be…

Chris Lange | Apr 11, 2018 at 9:05 AM EDT

Short Sellers Back Way Off Major Biotechs

The March 29 short interest data have been compared with the previous report, and short interest in most of the…

1 … 136 137 138 139 140 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Now Is the Best Time for Bellicum to Raise Cash

An Upcoming Drug May Emerge as the Winner in the War on Chronic Severe Gout

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

Johnson & Johnson Earnings Just Par for the Course

Why UnitedHealth Is Boasting Healthy Earnings

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Why NewLink Genetics Shares Hit an All-Time Low

Alkermes Wins Big on FDA Approval

Why Celldex Therapeutics Is Getting Crushed

Why 4 Top Biotech Stocks May Be the Next Takeover Targets

6 Biotech and Medtech Stocks That Saw Massive Moves Last Week

Bellicum Pharmaceuticals Wins Big With FDA Decision

Pfizer’s Kidney Drug Not Up to Par

Are Analogic Shareholders Getting Enough in the Buyout?

Short Sellers Back Way Off Major Biotechs

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

Health and Healthcare Articles

All Health and Healthcare Articles

Why Now Is the Best Time for Bellicum to Raise Cash

An Upcoming Drug May Emerge as the Winner in the War on Chronic Severe Gout

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

Johnson & Johnson Earnings Just Par for the Course

Why UnitedHealth Is Boasting Healthy Earnings

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Why NewLink Genetics Shares Hit an All-Time Low

Alkermes Wins Big on FDA Approval

Why Celldex Therapeutics Is Getting Crushed

Why 4 Top Biotech Stocks May Be the Next Takeover Targets

6 Biotech and Medtech Stocks That Saw Massive Moves Last Week

Bellicum Pharmaceuticals Wins Big With FDA Decision

Pfizer’s Kidney Drug Not Up to Par

Are Analogic Shareholders Getting Enough in the Buyout?

Short Sellers Back Way Off Major Biotechs

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Featured Reads

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?